Providing researchers access to valuable genetic and health data while protecting the individuals who provide it
#99 of 112 undisclosed-stage biotech startups
▲ 5 since the last ranking
Ranked 6:02 AM PT · Thu, Nov 19
Listed
Sano’s end-to-end precision medicine platform de-risks trials, enabling clinical operations teams to move 10x faster and reduce cost by 5x.
If a fact is wrong, or you want the profile removed, tell us: we act on every request within 2 business days.